Characterization of recombinant integrase of human immunodeficiency virus type 1 (isolate Bru)

被引:2
作者
Semenova, EA [1 ]
Gashnikova, NM [1 ]
Il'ina, TV [1 ]
Pronyaeva, TR [1 ]
Pokrovsky, AG [1 ]
机构
[1] State Res Ctr Virol & Biotechnol Vector, Inst Mol Biol, Koltsov 630559, Novosibirsk Reg, Russia
基金
俄罗斯基础研究基金会;
关键词
integrase; human immunodeficiency virus type 1; isolate Bru; aurintricarbonic acid;
D O I
10.1023/A:1026060512380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integration of the human immunodeficiency virus type 1 (HIV-1) DNA into the human genome requires the virus-encoded integrase protein. The recombinant integrase protein of HW-1 (isolate Bru) was prepared by constructing a plasmid based on pET-15b encoding the integrase gene. Integrase of HfV-1 was purified using a bacterial expression system (Escherichia coli). The main kinetic parameters of HIV-1 integrase (K-m = (3.7 +/- 0.2).10(-10) M, k(cat) = (1.2 +/- 0.3).10(-7) sec(-1)) were determined using an oligonucleotide duplex constructed on the basis of the U5-terminal sequence of proviral HIV-1 DNA as the substrate. Inhibition of integrase by aurintricarbonic acid ([I](50) = 6.3 +/- 0.4 muM) and dependence of integrase activity on Mg2+ and Mn2+ concentration were studied.
引用
收藏
页码:988 / 993
页数:6
相关论文
共 50 条
  • [41] Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update
    Shafer, Robert W.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S843 - S846
  • [42] Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1
    Wielens, Jerome
    Headey, Stephen J.
    Deadman, John J.
    Rhodes, David I.
    Parker, Michael W.
    Chalmers, David K.
    Scanlon, Martin J.
    CHEMMEDCHEM, 2011, 6 (02) : 258 - 261
  • [43] Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr)
    Gleenberg, Iris Oz
    Herschhorn, Alon
    Hizi, Amnon
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 369 (05) : 1230 - 1243
  • [44] Development of a Raltegravir-based Photoaffinity-Labeled Probe for Human Immunodeficiency Virus-1 Integrase Capture
    Pala, Nicolino
    Esposito, Francesca
    Tramontano, Enzo
    Singh, Pankaj Kumar
    Sanna, Vanna
    Carcelli, Mauro
    Haigh, Lisa D.
    Satta, Sandro
    Sechi, Mario
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1986 - 1992
  • [45] RECENT PROGRESS IN THE DEVELOPMENT OF INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE FOR THE MANAGEMENT OF HIV INFECTION
    Lin, S. S.
    Xu, F.
    Liao, P. -H.
    Yang, C. -C.
    ACTA VIROLOGICA, 2008, 52 (04) : 197 - 207
  • [46] Mutation patterns of integrase gene affect antiretroviral resistance in various non-B subtypes of human immunodeficiency virus Type-1 and their implications for patients' therapy
    Djojosugito, Fauzia A.
    Arfianti, Arfianti
    Wisaksana, Rudi
    Indrati, Agnes R.
    BIOMEDICINE-TAIWAN, 2023, 13 (04): : 1 - 9
  • [47] A three-dimensional model of the human immunodeficiency virus type 1 integration complex
    Wielens, J
    Crosby, IT
    Chalmers, DK
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (05) : 301 - 317
  • [48] Repurposing integrase inhibitors against human T-lymphotropic virus type-1: a computational approach
    Sinha, Prashasti
    Yadav, Anil Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [49] Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239
    Hassounah, Said A.
    Liu, Yannan
    Quashie, Peter K.
    Oliveira, Maureen
    Moisi, Daniela
    Brenner, Bluma G.
    Sandstrom, Paul A.
    Mesplede, Thibault
    Wainberg, Mark A.
    JOURNAL OF VIROLOGY, 2015, 89 (23) : 12002 - 12013
  • [50] Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments
    Menendez-Arias, Luis
    ANTIVIRAL RESEARCH, 2013, 98 (01) : 93 - 120